Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$30,000,460
+$434,954 QoQ
Shares Held
118,126
-2.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.44%
of 13F equity value
Holder Rank
#588
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calamos Wealth Management LLC holds $79,224,350 across 11 Drug Manufacturers - General names. JNJ ranks #2 (37.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
31,177 | $37,394,632 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
118,126 | $30,000,460 | |
| 3 | ABBV |
AbbVie Inc.
|
15,919 | $4,005,857 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,811 | $2,674,213 | |
| 5 | PFE |
Pfizer Inc
|
65,212 | $1,570,304 | |
| 6 | AMGN |
Amgen Inc
|
2,408 | $871,984 | |
| 7 | AZN |
Astrazeneca PLC
|
4,208 | $797,920 | |
| 8 | NVS |
Novartis AG
|
4,898 | $767,614 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,000,460 | 118,126 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $29,565,506 | 120,952 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $26,292,583 | 127,048 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $23,728,939 | 127,974 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $18,350,010 | 120,131 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $19,302,780 | 116,394 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $14,598,955 | 100,947 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $6,891,277 | 42,523 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,260,617 | 42,834 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $5,580,468 | 35,277 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $4,818,344 | 30,741 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $3,186,800 | 20,461 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $3,146,204 | 19,008 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $2,984,060 | 19,252 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $3,465,166 | 19,616 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $3,184,703 | 19,495 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $3,920,308 | 22,085 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $3,950,456 | 22,290 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $3,546,794 | 20,733 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $3,545,248 | 21,952 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $3,724,277 | 22,607 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $3,641,831 | 22,159 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $3,274,605 | 20,807 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $2,291,709 | 15,393 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $2,122,387 | 15,092 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $2,139,779 | 16,318 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||